vaccines-world-2017-scientifictracks-abstracts

4 / 15

alliedacademies
Virology Research Journal
Volume 1 Issue 4 Vaccines World 2017
Page 16
November 09-10, 2017 Vienna, Austria
21st World Congress and Exhibition on
VACCINES, VACCINATION & IMMUNIZATION
Ethical issues in the production, design and clinical
trials of new vaccines for emerging diseases in low
income countries
Ida Cristina Gubert
Federal University of Parana, Brazil
Statement of the Problem: Since first developed by Jenner
and Pasteur vaccines have shown to be an important tool for
the eradication (cow pox) and prevention of communicable
diseases with high morbidity and mortality rates, and became
one component of public health policies. However, good
quality housing, appropriate disposal of sewage, nutrition,
education and adequate sanitary conditions have also been
an important determinant in health promotion. In this way,
upper level societies have witnessed a significant reduction
of diseases such as zoonosis, communicable diseases and
vector born infections. Nevertheless, populations in low
income countries still face poor sanitary and living conditions
which contribute to the emergence of new diseases. Recently
countries in Latin America witnessed the epidemics of a
vector borne viral infection that resulted in microcephaly to
the fetuses born from infected women.
Purpose: The purpose of this text is to present a reflection
on the life conditions of these populations, their vulnerability,
the need for new vaccines, the public health policies to be
implemented and the ethical issues to be considered in this
reality.
Methodology: An analysis on the ethical issues concerning
the development of new vaccines and their trials in low
income countries.
Conclusion & Significance: It is undeniable all benefits
that have been reached in health promotion through
immunization protocols worldwide. However insufficient
supply, the rationale of use and distribution of vaccines in low
income countries, the health condition of the participants in
the trials, inclusion and exclusion criteria, the comparative
arm, the inclusion of pregnant women, risks and benefits,
the availability of the final product once trial is finished and
the voluntary or compulsory character of immunization are
some of the ethical issues that deserve consideration in the
development and distribution of vaccines as a part of public
health policies in low income countries.
Recent Publications :
• GUBERT, I. C.. Conflitos e abordagem bioética de crianças
com distúrbios do desenvolvimento sexual. Revista Pistis
Praxis, v. 4, p. 33-40, 2012.
• GUBERT, I. C.; SANCHES, M. A. (Org.) . bioética e
vulnerabilidades. 1a. Ed. Curitiba: Editora Champagnat e
Editora da UFPR, 2012. v. 1. 220p.
• GUBERT, I. C.; ROCCO, C. S. . GENÉTICA E
VULNERABILIDADE. In: Ida Cristina Gubert e Mário
Antônio Sanches. (Org.). Bioética e Vulnerabilidade. 1ed.
Curitiba: Editora Champagnat e Editora UFPR, 2012, v. 1,
p. 31-51.
• GUBERT, I. C.; MIRANDA, M. C. M. ; MALCA, E. Q. . La
investigación en vacunas y enfermedades desatendidas:un
aspecto relegado en la ética de la investigación?. In:
Francisco Javier Leon Correa e Patrícia Sorokin. (Org.).
Bioética y Salud Pública en y para America Latina. 1ed.
Chile: FELAIBE, 2015, v. , p. 8-492.
• GUBERT,I.C . INVESTIGACIÓN DE VACUNAS EN
PEDIATRÍA: PERSPECTIVAS BIOÉTICAS Y DE SALUD
PÚBLICA. Available in Research Gate. DOI: 10.13140/
RG.2.1.3839.6567 • 10/2015
• ROCCO,C.S.;GUBERT,I.C..INTERVENÇÃODIETÉTICA
NAS DOENÇAS NEUROLÓGICAS NA INFÂNCIA:
conflitos éticos e bioéticos.. In: Caroline Filla Rosaneli.
(Org.). Contextos, conflitos e escolhas em Alimentação
e Bioética. 1ed.Curitiba: EDITORA UNIVERSITÁRIA
CHAMPAGNAT, 2016, v. 1, p. 125-140.
• CARLA SENZ C, ALGER J, BECA JP, BELIZÁN JM,
CAFFERATA ML, CANARIO GUZMÁN JA et al. Un
llamado ético a la inclusión de mujeres embarazadas en
investigación. Rev Panam Salud Publica. 2017;41:e13.
Biography
Bachelor degree in Biological Sciences from Universidade Federal do Paraná
(1975), masters Degree in Genetics from Universidade Federal do Paraná
(1986) and PhD in Biochemical and Molecular Pharmacology from Universidade
Federal de Minas Gerais (2005) and Post-Doc in Bioethics in Clinical Research
( Facultad Latino Americana de Ciências Sociales, FLACSO, Argentina). Has
experience in Immunology, focusing on Applied Imunology, acting on the
following subjects: Immunology and Public Health. Chair Ethics Commitee in
Research at Universidade Federal do Paraná and member of Group of Studies
in Bioethics ( NEB) , Curitiba, PR.
Ida Cristina Gubert, Virol Res J 2017, 1:4